Resveratrol: a Potential Anti-remodeling Agent in Heart Failure, From Bench to Bedside
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Resveratrol (Primary)
- Indications Cardiomyopathies; Left ventricular dysfunction
- Focus Therapeutic Use
- 14 Nov 2018 Biomarkers information updated
- 18 Aug 2013 New trial record